Interventions for replacing missing teeth: different times for loading dental implants.

This paper reminds readers of this journal of an important source of summaries of the evidence for effectiveness of healthcare interventions, namely the Cochrane Database of Systematic Reviews.

[1]  J. Eggermont,et al.  The neuroscience of tinnitus , 2004, Trends in Neurosciences.

[2]  G. Hofmeyr,et al.  Buccal or sublingual misoprostol for cervical ripening and induction of labour. , 2004, The Cochrane database of systematic reviews.

[3]  B. Ben-Zeev,et al.  Sulthiame in childhood epilepsy , 2004, Pediatrics international : official journal of the Japan Pediatric Society.

[4]  B. Mol,et al.  Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. , 2004, Human reproduction.

[5]  I. Adam,et al.  Oral misoprostol vs. vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second‐trimester , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[6]  V. Neugebauer,et al.  The Amygdala and Persistent Pain , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[7]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[8]  Daniel L. Riddle,et al.  Impact of Demographic and Impairment-Related Variables on Disability Associated with Plantar Fasciitis , 2004, Foot & ankle international.

[9]  J B McKinlay,et al.  Prevalence of foot and ankle conditions in a multiethnic community sample of older adults. , 2004, American journal of epidemiology.

[10]  D. Grimes,et al.  Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial , 2004, BJOG : an international journal of obstetrics and gynaecology.

[11]  K. Barnhart,et al.  A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure. , 2004, American journal of obstetrics and gynecology.

[12]  C. Ghetti.  Incorporating Music Therapy into the Harm Reduction Approach to Managing Substance Use Problems , 2004 .

[13]  A. Campana,et al.  Medical methods for first trimester abortion. , 2004, The Cochrane database of systematic reviews.

[14]  D. Roter,et al.  Teaching communication skills: an AACE survey of oncology training programs. , 2004, Journal of cancer education : the official journal of the American Association for Cancer Education.

[15]  R. Müller-Peddinghaus,et al.  The antipsoriatic drug, anthralin, inhibits protein kinase C — implications for its mechanism of action , 2004, Archives of Dermatological Research.

[16]  K. Kragballe,et al.  Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes , 2004, Archives of Dermatological Research.

[17]  D. Pyne,et al.  Factors Affecting Running Economy in Trained Distance Runners , 2004, Sports medicine.

[18]  Z. Alfirevic,et al.  Treatment for primary postpartum haemorrhage. , 2014, The Cochrane database of systematic reviews.

[19]  G. Hofmeyr,et al.  Vaginal misoprostol for cervical ripening and induction of labour , 2010 .

[20]  J. B. Rosefsky.  Results of clinical trials sponsored by for-profit vs nonprofit entities. , 2003, JAMA.

[21]  Y. Niwa,et al.  Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin , 2003, The British journal of dermatology.

[22]  K. Nicolaides,et al.  Fetal loss following ultrasound diagnosis of a live fetus at 6–10 weeks of gestation , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[23]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[24]  A. Borgida,et al.  A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination. , 2003, American journal of obstetrics and gynecology.

[25]  A. Ziv,et al.  Simulation-based medical education: an ethical imperative. , 2006, Simulation in healthcare : journal of the Society for Simulation in Healthcare.

[26]  Andrea Gaggioli,et al.  Virtual Reality Training for Health-Care Professionals , 2003, Cyberpsychology Behav. Soc. Netw..

[27]  Michele Leone,et al.  Restoration of partially edentulous patients using dental implants with a microtextured surface: a prospective comparison of delayed and immediate full occlusal loading. , 2003, The International journal of oral & maxillofacial implants.

[28]  K. O'Brien,et al.  Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults. , 2003, The Journal of infectious diseases.

[29]  L. Rosenhall,et al.  One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma. , 2003, Respiratory medicine.

[30]  B. Beermann,et al.  Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications , 2003, BMJ : British Medical Journal.

[31]  B. Lipworth,et al.  Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. , 2003, American journal of respiratory and critical care medicine.

[32]  K. H. Gülkesen,et al.  Effects of oral montelukast on airway function in acute asthma. , 2003, Respiratory medicine.

[33]  N. Usen,et al.  Plantar fasciitis: a degenerative process (fasciosis) without inflammation. , 2003, Journal of the American Podiatric Medical Association.

[34]  Onchee Yu,et al.  Effectiveness of pneumococcal polysaccharide vaccine in older adults. , 2003, The New England journal of medicine.

[35]  B. Kröner-Herwig,et al.  The management of chronic tinnitus: comparison of an outpatient cognitive-behavioral group training to minimal-contact interventions. , 2003, Journal of psychosomatic research.

[36]  M. Maeder-Ingvar,et al.  Treatment with Sulthiame (Ospolot) in benign partial epilepsy of childhood and related syndromes: an open clinical and EEG study. , 2003, Neuropediatrics.

[37]  Systematic Reviews, the Cochrane Collaboration and Hand Therapy , 2003 .

[38]  J. Zorc,et al.  Scheduled follow-up after a pediatric emergency department visit for asthma: a randomized trial. , 2003, Pediatrics.

[39]  L. Poulter,et al.  Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation. , 2003, American journal of respiratory and critical care medicine.

[40]  D. Price,et al.  Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma , 2003, Thorax.

[41]  C. Camargo,et al.  A randomized controlled trial of intravenous montelukast in acute asthma. , 2003, American journal of respiratory and critical care medicine.

[42]  B. Lipworth,et al.  Montelukast confers complimentary non-steroidal anti-inflammatory activity in asthmatics receiving fluticasone alone and fluticasone/salmeterol combination , 2003 .

[43]  D. Kaufman,et al.  Applying educational theory in practice , 2003, BMJ : British Medical Journal.

[44]  C. Gross,et al.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.

[45]  R. Schwartz,et al.  Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[46]  A. Tawse‐Smith,et al.  Conventional and early loading of unsplinted ITI implants supporting mandibular overdentures. , 2002, Clinical oral implants research.

[47]  E. Israel,et al.  Effects of montelukast and beclomethasone on airway function and asthma control. , 2002, The Journal of allergy and clinical immunology.

[48]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[49]  P. O'Byrne,et al.  Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. , 2002, American journal of respiratory and critical care medicine.

[50]  Ø. Lidegaard,et al.  Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi‐center trial in Copenhagen county, Denmark , 2002, Acta obstetricia et gynecologica Scandinavica.

[51]  H. Magnussen,et al.  Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma , 2002, European Respiratory Journal.

[52]  H. Magnussen,et al.  Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma , 2002, European Respiratory Journal.

[53]  P. Maguire,et al.  Key communication skills and how to acquire them , 2002, BMJ : British Medical Journal.

[54]  O. Rampon,et al.  Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children , 2002, European Respiratory Journal.

[55]  P. Bower,et al.  Patient-centred consultations and outcomes in primary care: a review of the literature. , 2002, Patient education and counseling.

[56]  G. Bonsel,et al.  Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation. , 2002, Human reproduction.

[57]  A Standardized Composite Clinical Score for Inhaled Corticosteroids Taper Studies in Asthma* , 2002 .

[58]  L. Edwards,et al.  Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma. , 2002, The American journal of medicine.

[59]  Josemir W Sander,et al.  Sulthiame in adults with refractory epilepsy and learning disability: an open trial , 2002, Epilepsy Research.

[60]  B. Lipworth,et al.  Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma. , 2002, Chest.

[61]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[62]  P. Nicolai,et al.  Comparison of Oral Montelukast and Inhaled Fluticasone in the Treatment of Asthma Associated with Chronic Rhinopolyposis: A Single-Blind, Randomized, Pilot Study , 2002 .

[63]  J. Lötvall,et al.  Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. , 2002, The Journal of allergy and clinical immunology.

[64]  N. Waugh,et al.  Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults. , 2002, Vaccine.

[65]  J. Taunton,et al.  Plantar fasciitis: a retrospective analysis of 267 cases , 2002 .

[66]  F. Santilli,et al.  Effectiveness of Montelukast versus Budesonide on Quality of Life and Bronchial Reactivity in Subjects with Mild-Persistent Asthma , 2002, International journal of immunopathology and pharmacology.

[67]  M. Lloyd,et al.  Professional attitudes: can they be taught and assessed in medical education? , 2002, Clinical medicine.

[68]  M. Nagashima,et al.  Comparative study between thromboembolism and total knee arthroplasty with or without tourniquet in rheumatoid arthritis patients , 2002, Archives of Orthopaedic and Trauma Surgery.

[69]  G. Wiedemann,et al.  The Family Questionnaire: Development and validation of a new self-report scale for assessing expressed emotion , 2002, Psychiatry Research.

[70]  P. Rytilä,et al.  Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients. , 2002, Respiratory medicine.

[71]  P. Kuna,et al.  [Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children]. , 2002, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[72]  S. Evans,et al.  The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. , 2002, American journal of obstetrics and gynecology.

[73]  P. Dorinsky,et al.  Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[74]  Christopher J Cates,et al.  Simpson's paradox and calculation of number needed to treat from meta-analysis , 2002, BMC medical research methodology.

[75]  R. Gilbert,et al.  Antibiotics versus control for toxoplasma retinochoroiditis. , 2002, The Cochrane database of systematic reviews.

[76]  P. Dicpinigaitis,et al.  Antitussive Effect of the Leukotriene Receptor Antagonist Zafirlukast in Subjects with Cough-Variant Asthma* , 2002, The Journal of asthma : official journal of the Association for the Care of Asthma.

[77]  I. Pavord,et al.  A placebo controlled comparison of formoterol, montelukast or higher dose of inhaled corticosteroids in subjects with symptomatic asthma despite treatment with low dose inhaled corticosteroids , 2002 .

[78]  C. Lemière,et al.  First line anti-inflammatory treatment for asthma: Inhaled steroid or leukotriene antagonist? , 2002 .

[79]  R. Pauwels,et al.  Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.

[80]  J. Puig-Barberá,et al.  [Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis]. , 2002, Atencion primaria.

[81]  W. Thomson,et al.  Early loading of unsplinted implants supporting mandibular overdentures using a one-stage operative procedure with two different implant systems: a 2-year report. , 2002, Clinical implant dentistry and related research.

[82]  L. Dubertret,et al.  [Psoriasis of the scalp]. , 2002, Annales de dermatologie et de venereologie.

[83]  S D Bianchi,et al.  Early loading of sandblasted and acid-etched (SLA) implants: a prospective split-mouth comparative study. , 2001, Clinical oral implants research.

[84]  B. Lipworth,et al.  Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[85]  G. Makoul.  The SEGUE Framework for teaching and assessing communication skills. , 2001, Patient education and counseling.

[86]  R. Zatorre,et al.  Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[87]  I. Haslock,et al.  Risk factors associated with the development of plantar heel pain in athletes , 2001 .

[88]  P. Dorinsky,et al.  Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone. , 2001, American journal of respiratory and critical care medicine.

[89]  R. Nathan,et al.  A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma. , 2001, The American journal of medicine.

[90]  A. Rizzo,et al.  The application of virtual reality technology in rehabilitation. , 2001 .

[91]  C. Pantev,et al.  Cortical reorganization in patients with high frequency cochlear hearing loss , 2001, Hearing Research.

[92]  S. Yancey,et al.  Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids. , 2001, MedGenMed : Medscape general medicine.

[93]  M. Chiapasco,et al.  Implant-retained mandibular overdentures with Brånemark System MKII implants: a prospective comparative study between delayed and immediate loading. , 2001, The International journal of oral & maxillofacial implants.

[94]  X. Xiang,et al.  [Influence of zafirlukast on pulmonary functions and quality of life in patients with asthma]. , 2001, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University.

[95]  A. González-Quintela,et al.  Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[96]  T. Reiss,et al.  Long‐term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[97]  G. Altomare,et al.  A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults. , 2001, European journal of dermatology : EJD.

[98]  M. Di Gioacchino,et al.  Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma. , 2001, International journal of immunopathology and pharmacology.

[99]  G. Guyatt,et al.  Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. , 2001, JAMA.

[100]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[101]  K. Zerres,et al.  The Predictive Value of Achieved Motor Milestones Assessed in 441 Patients with Infantile Spinal Muscular Atrophy Types II and III , 2001, European Neurology.

[102]  E. Meltzer,et al.  Desloratadine: A new, nonsedating, oral antihistamine. , 2001, The Journal of allergy and clinical immunology.

[103]  B. Lipworth,et al.  Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids. , 2001, Chest.

[104]  G. Makoul,et al.  Essential Elements of Communication in Medical Encounters: The Kalamazoo Consensus Statement , 2001, Academic medicine : journal of the Association of American Medical Colleges.

[105]  J. Hedlund,et al.  Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study , 2001, The Lancet.

[106]  Choon-Sik Park,et al.  Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild‐to‐moderate asthma: A 4 week randomized multicentre controlled trial , 2001, Respirology.

[107]  L. Boulet,et al.  What is new since the last (1999) Canadian Asthma Consensus Guidelines? , 2001, Canadian respiratory journal.

[108]  J. Ward,et al.  Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[109]  B. Lipworth,et al.  Effects of monotherapy with intra‐nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[110]  T. Reiss,et al.  Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[111]  K. Yamauchi,et al.  Effects of Pranlukast, a Leukotriene Receptor Antagonist, on Airway Inflammation in Mild Asthmatics , 2001, Journal of Asthma.

[112]  L. Allegra,et al.  Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma. , 2001, European review for medical and pharmacological sciences.

[113]  L. Edwards,et al.  Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[114]  B. Leventhal,et al.  The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.

[115]  B. Lipworth,et al.  Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma. , 2000, American journal of respiratory and critical care medicine.

[116]  A. Schuchat,et al.  Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. , 2000, Archives of internal medicine.

[117]  L. Naugle,et al.  Kirkpatrick's Evaluation Model as a Means of Evaluating Teacher Performance , 2000 .

[118]  A. Becker.  Leukotriene receptor antagonists: Efficacy and safety in children with asthma , 2000, Pediatric pulmonology.

[119]  D. Stempel.  Montelukast added to inhaled beclomethasone in treatment of asthma. , 2000, American journal of respiratory and critical care medicine.

[120]  Toshiyuki Yamamoto,et al.  Topical Anthralin for Psoriasis Vulgaris: Evaluation of 70 Japanese Patients , 2000, The Journal of dermatology.

[121]  H. Bisgaard,et al.  Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. , 2000, American journal of respiratory and critical care medicine.

[122]  R. Reading.  Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment , 2000 .

[123]  H. Bisgaard,et al.  Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). , 2000, Respiratory medicine.

[124]  Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids. , 2000, Chest.

[125]  R. Dockhorn,et al.  Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients , 2000, Thorax.

[126]  R. Tweedie,et al.  A Nonparametric “Trim and Fill” Method of Accounting for Publication Bias in Meta-Analysis , 2000 .

[127]  H. Pasma,et al.  Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma. , 2000, Respiratory medicine.

[128]  M. Stanford,et al.  Is ocular toxoplasmosis caused by prenatal or postnatal infection? , 2000, The British journal of ophthalmology.

[129]  R C George,et al.  Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis , 2000, BMJ : British Medical Journal.

[130]  Sakamoto,et al.  Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin‐intolerant asthma , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[131]  L. Kohn,et al.  COMMITTEE ON QUALITY OF HEALTH CARE IN AMERICA , 2000 .

[132]  D. Adrian,et al.  The epidemiology of tinnitus , 2000 .

[133]  J. Neilson,et al.  Ultrasound for fetal assessment in early pregnancy. , 2000, The Cochrane database of systematic reviews.

[134]  H. Blau,et al.  Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma. , 1999, The Journal of allergy and clinical immunology.

[135]  C. Prefaut,et al.  The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness. , 1999, The Journal of allergy and clinical immunology.

[136]  A. Sampson,et al.  Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients , 1999, Thorax.

[137]  K. Nichol,et al.  The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. , 1999, Archives of internal medicine.

[138]  H. Bisgaard,et al.  NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. , 1999, American journal of respiratory and critical care medicine.

[139]  M. Stanford,et al.  Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications , 1999, Epidemiology and Infection.

[140]  F. Enneking,et al.  Cerebral microembolism diagnosed by transcranial Doppler during total knee arthroplasty: correlation with transesophageal echocardiography. , 1999, Anesthesiology.

[141]  J. Thistlethwaite,et al.  Patient‐centred consultations: a comparison of student experience and understanding in two clinical environments , 1999, Medical education.

[142]  K. Nichol.  The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. , 1999, Vaccine.

[143]  E. Israel,et al.  Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients , 1999, BMJ.

[144]  P. Branemark,et al.  Brånemark Novum: a new treatment concept for rehabilitation of the edentulous mandible. Preliminary results from a prospective clinical follow-up study. , 1999, Clinical implant dentistry and related research.

[145]  M. Leinonen,et al.  Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. , 1999, Vaccine.

[146]  J. Lötvall,et al.  Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. , 1999, American journal of respiratory and critical care medicine.

[147]  W. Busse,et al.  Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma. , 1999, The Journal of allergy and clinical immunology.

[148]  R. Gilbert,et al.  Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling , 1999, The Lancet.

[149]  Lynn Wei,et al.  Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma , 1999, Annals of Internal Medicine.

[150]  C. Bonuccelli,et al.  The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children. , 1999, The Journal of pediatrics.

[151]  J. Kemp,et al.  Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma. , 1999, Chest.

[152]  F. Roberts,et al.  Pathogenesis of toxoplasmic retinochoroiditis. , 1999, Parasitology today.

[153]  Diamant,et al.  The effect of montelukast (MK‐0476), a cysteinyl leukotriene receptor antagonist, on allergen‐induced airway responses and sputum cell counts in asthma , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[154]  K. Aspegren.  BEME Guide No. 2: Teaching and learning communication skills in medicine-a review with quality grading of articles. , 1999, Medical teacher.

[155]  J. Bernstein,et al.  Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. , 1999, JAMA.

[156]  P. C. van de Kerkhof,et al.  Scalp Psoriasis, Clinical Presentations and Therapeutic Management , 1998, Dermatology.

[157]  S. Spector,et al.  Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. , 1998, The Journal of allergy and clinical immunology.

[158]  J. Irrgang,et al.  Outcome Study of Subjects with Insertional Plantar Fasciitis , 1998, Foot & ankle international.

[159]  Joseph W. Hall,et al.  Perceptual consequences of peripheral hearing loss: do edge effects exist for abrupt cochlear lesions? , 1998, Hearing Research.

[160]  G. Penney,et al.  An effective regimen for early medical abortion: a report of 2000 consecutive cases. , 1998, Human reproduction.

[161]  A. T. Berman,et al.  The Incidence of Large Venous Emboli During Total Knee Arthroplasty Without Pneumatic Tourniquet Use , 1998, Anesthesia and analgesia.

[162]  P. O'Byrne,et al.  Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. , 1998, The Journal of allergy and clinical immunology.

[163]  L Hendeles,et al.  Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. , 1998, The New England journal of medicine.

[164]  P. C. van de Kerkhof,et al.  Evaluation of Topical Drug Treatment in Psoriasis , 1998, Dermatology.

[165]  L. Smith,et al.  A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[166]  R. Dockhorn,et al.  Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. , 1998, Archives of internal medicine.

[167]  J. Isaac-Renton,et al.  Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. , 1998, Ophthalmology.

[168]  Williams,et al.  The diagnosis of psoriasis: diagnostic criteria , 1998, The British journal of dermatology.

[169]  P. Barnes,et al.  Effect of inhaled corticosteroids on bones and growth. , 1998, The European respiratory journal.

[170]  D. Fedson.  Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[171]  J. Dickinson,et al.  Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. , 1998, The Journal of maternal-fetal medicine.

[172]  K. Chandrasekaran,et al.  Emboli Observed with Use of Transesophageal Echocardiography Immediately after Tourniquet Release during Total Knee Arthroplasty with Cement* , 1998, The Journal of bone and joint surgery. American volume.

[173]  L. Dubé,et al.  A Randomized Controlled Trial Comparing Zileuton With Theophylline in Moderate Asthma , 1998 .

[174]  B. Sibbald,et al.  Understanding controlled trials: Why are randomised controlled trials important? , 1998 .

[175]  George Davey Smith,et al.  meta-analysis bias in location and selection of studies , 1998 .

[176]  G. Bootsma,et al.  Effects of inhaled corticosteroids on bone. , 1998, The Netherlands journal of medicine.

[177]  D. Sackett,et al.  Choosing the best research design for each question , 1997, BMJ.

[178]  H. Hoffman,et al.  Virtual reality: teaching tool of the twenty‐first century? , 1997, Academic medicine : journal of the Association of American Medical Colleges.

[179]  E. Israel,et al.  Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air. , 1997, Thorax.

[180]  I. Naya,et al.  Comparative efficacy of zafirlukast and low dose steroids in asthmatics on prn beta2-agonists , 1997 .

[181]  A J Moskowitz,et al.  Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. , 1997, JAMA.

[182]  J. Melki,et al.  Spinal muscular atrophy. , 1997, Current opinion in neurology.

[183]  M. Leinonen,et al.  Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. , 1997, The American journal of medicine.

[184]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[185]  J. Kemp,et al.  Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group. , 1997, Clinical therapeutics.

[186]  J. Ayres,et al.  Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease , 1997, BMJ.

[187]  N. Barnes,et al.  Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma. , 1997, Thorax.

[188]  N. Barnes,et al.  Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers. , 1997, Thorax.

[189]  M. Leinonen,et al.  Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly population. , 1997, International journal of epidemiology.

[190]  P. Tugwell,et al.  Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. , 1997, The Journal of rheumatology.

[191]  Y. Herabutya,et al.  Misoprostol in the management of missed abortion , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[192]  K. Zerres,et al.  A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients , 1997, Journal of the Neurological Sciences.

[193]  S. Suissa,et al.  Effectiveness of the Leukotriene Receptor Antagonist Zafirlukast for Mild-to-Moderate Asthma , 1997, Annals of Internal Medicine.

[194]  J Zhang,et al.  Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. , 1997, Thorax.

[195]  V. Royston.  How do medical students learn to communicate with patients? A study of fourth-year medical students' attitudes to doctor-patient communication , 1997 .

[196]  W. Busse,et al.  Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist. , 1997, The Journal of asthma : official journal of the Association for the Care of Asthma.

[197]  L. Dubé,et al.  Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial , 1996 .

[198]  S. Iannaccone,et al.  Function changes in spinal muscular atrophy II and III , 1996, Neurology.

[199]  J Zhang,et al.  Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma. , 1996, The Journal of allergy and clinical immunology.

[200]  K. Hsieh.  Evaluation of efficacy of traditional Chinese medicines in the treatment of childhood bronchial asthma: clinical trial, immunological tests and animal study , 1996, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[201]  R. Beveridge,et al.  Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[202]  A. Faúndes,et al.  Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. , 1996, Contraception.

[203]  E. Israel,et al.  Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. , 1996, JAMA.

[204]  A. Jadad,et al.  The importance of quality of primary studies in producing unbiased systematic reviews. , 1996, Archives of internal medicine.

[205]  D. Rennie,et al.  Influences on the Quality of Published Drug Studies , 1996, International Journal of Technology Assessment in Health Care.

[206]  D. Brocks,et al.  The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers , 1996, European Journal of Clinical Pharmacology.

[207]  M. Fisch,et al.  Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. , 1995, Archives of internal medicine.

[208]  K. Schulz,et al.  Subverting randomization in controlled trials. , 1995, JAMA.

[209]  E. Israel,et al.  Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.

[210]  S. Wenzel,et al.  Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. , 1995, American journal of respiratory and critical care medicine.

[211]  A. Kamada,et al.  Glucocorticoids and growth in asthmatic children , 1995, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[212]  D. Newham.  The Cochrane Collaboration: What Is It, How Does It Work, and What Has It To Do With Physiotherapy? , 1995 .

[213]  J. Voorhees,et al.  Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. , 1995, The Journal of investigative dermatology.

[214]  T G McPoil,et al.  Evaluation and management of foot and ankle disorders: present problems and future directions. , 1995, The Journal of orthopaedic and sports physical therapy.

[215]  M. Stewart.  Effective physician-patient communication and health outcomes: a review. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[216]  F. Ruben.  Counterpoint to 'pneumococcal vaccine after 15 years of use'. , 1995, Archives of internal medicine.

[217]  J. Brown.  Patient-centred medicine: Transforming the clinical method , 1998 .

[218]  K. Eyres,et al.  Effects of tourniquet during total knee arthroplasty. A prospective randomised study. , 1995, The Journal of bone and joint surgery. British volume.

[219]  I. Jónsdóttir,et al.  Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? , 1995, Immunology today.

[220]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[221]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[222]  Neonatal serologic screening and early treatment for congenital toxoplasma gondii infection , 1995 .

[223]  A. Detsky,et al.  Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. , 1994, Archives of internal medicine.

[224]  A. Couteur,et al.  Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.

[225]  T. Haahtela,et al.  Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. , 1994, The New England journal of medicine.

[226]  C. Mulrow,et al.  Systematic Reviews: Rationale for systematic reviews , 1994 .

[227]  M. Nagata,et al.  Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. , 1994, American journal of respiratory and critical care medicine.

[228]  V. Keller,et al.  A new model for physician-patient communication. , 1994, Patient education and counseling.

[229]  H. Nelson,et al.  Effect of RG 12525, a new leukotriene antagonist, on pulmonary function of asthmatic adults. , 1994, Annals of allergy.

[230]  M. Wolgin,et al.  Conservative Treatment of Plantar Heel Pain: Long-Term Follow-Up , 1994, Foot & ankle international.

[231]  Benjamin A Lipsky,et al.  The pneumococcal vaccine after 15 years of use. , 1994, Archives of internal medicine.

[232]  G. G. Kent,et al.  The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions , 1994, The British journal of dermatology.

[233]  B. Bonnekoh,et al.  Anthralin: how does it act and are there more favourable derivatives? , 1994, Acta dermato-venereologica. Supplementum.

[234]  W. Busse,et al.  The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma , 1993, Annals of Internal Medicine.

[235]  R. Breiman,et al.  Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. , 1993, JAMA.

[236]  L. Smith,et al.  Inhibition of leukotriene D4‐induced bronchoconstriction in subjects with asthma: a concentration‐effect study of ICI 204,219 , 1993, Clinical pharmacology and therapeutics.

[237]  W. McIlroy,et al.  Should unpublished data be included in meta-analyses? Current convictions and controversies. , 1993, JAMA.

[238]  Asthma, inflammation, and airway hyperresponsiveness in children. , 1993, Current opinion in pediatrics.

[239]  A Rothova,et al.  Ocular involvement in toxoplasmosis. , 1993, The British journal of ophthalmology.

[240]  M. Vessey,et al.  Misoprostol and illegal abortion in Rio de Janeiro, Brazil , 1993, The Lancet.

[241]  R. Frydman,et al.  Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial. , 1993, Human reproduction.

[242]  M. Fujimura,et al.  Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. , 1993, Respiratory medicine.

[243]  F. Plummer,et al.  The Role of Maternal Syphilis, Gonorrhoea and HIV-1 Infections in Spontaneous Abortion , 1992, International journal of STD & AIDS.

[244]  N. Steven,et al.  Pneumococcal immunisation and the healthy elderly , 1992, The Lancet.

[245]  E. Mitchell.  Consensus on acute asthma management in children. Ad Hoc Paediatric Group. , 1992, The New Zealand medical journal.

[246]  M. Goldstein,et al.  Teaching medical interviewing. A basic course on interviewing and the physician-patient relationship. , 1992, Archives of internal medicine.

[247]  P. Kerkhof,et al.  Scarring alopecia and psoriasis , 1992, The British journal of dermatology.

[248]  S. Findlay,et al.  Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma. , 1992, The Journal of allergy and clinical immunology.

[249]  M. Freeman,et al.  Early migration of prostheses related to long-term survivorship. Comparison of tibial components in knee replacement. , 1992, The Journal of bone and joint surgery. British volume.

[250]  M. C. Peterson,et al.  Contributions of the history, physical examination, and laboratory investigation in making medical diagnoses. , 1992, The Western journal of medicine.

[251]  R. Chalmers,et al.  The role of streptococcal infection in the initiation of guttate psoriasis. , 1992, Archives of dermatology.

[252]  M. Stewart,et al.  Doctor-patient communication: the Toronto consensus statement. , 1991, BMJ.

[253]  R. Adair,et al.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. , 1991, The New England journal of medicine.

[254]  A. Tattersfield,et al.  Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma. , 1991, British journal of clinical pharmacology.

[255]  R. Pauwels,et al.  MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human. , 1991, The American review of respiratory disease.

[256]  J. Barker.  The pathophysiology of psoriasis , 1991, The Lancet.

[257]  K. P. Hui,et al.  Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist , 1991, The Lancet.

[258]  D. Jabs,et al.  Current practices in the management of ocular toxoplasmosis. , 1991, American journal of ophthalmology.

[259]  J. Frost,et al.  A Retrospective Study of Spontaneous Remission and Long‐Term Outcome in Patients with Infantile Spasms , 1991, Epilepsia.

[260]  S. Spector,et al.  677 The therapeutic effects of MK-571, a potent and selective leukotriene (LT) D4 receptor antagonist, in patients with chronic asthma , 1991 .

[261]  G H Guyatt,et al.  Agreement among reviewers of review articles. , 1991, Journal of clinical epidemiology.

[262]  Paul H. Rubin,et al.  The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. , 1990, The New England journal of medicine.

[263]  F K Kuk,et al.  The psychometric properties of a tinnitus handicap questionnaire. , 1990, Ear and hearing.

[264]  G. Miller.  The assessment of clinical skills/competence/performance , 1990, Academic medicine : journal of the Association of American Medical Colleges.

[265]  American College of Sports Medicine position stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. , 1990, Medicine and science in sports and exercise.

[266]  P A Schnitman,et al.  Immediate fixed interim prostheses supported by two-stage threaded implants: methodology and results. , 1990, The Journal of oral implantology.

[267]  A. Sheffer,et al.  A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. , 1989, The American review of respiratory disease.

[268]  D. Graham,et al.  Painful Heel Syndrome: Radiographic and Treatment Assessment , 1988, Foot & ankle.

[269]  J. Schwartz,et al.  The clinical effectiveness of pneumococcal vaccine in the elderly. , 1988, Annals of internal medicine.

[270]  D. Jahnigen,et al.  Inefficacy of pneumococcal vaccine in a high-risk population. , 1987, The American journal of medicine.

[271]  C. Aranda,et al.  Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study. , 1987, Chest.

[272]  J. Leech,et al.  Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[273]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[274]  A. Cross,et al.  Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. , 1986, The New England journal of medicine.

[275]  I. Cameron,et al.  Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost). , 1986, Contraception.

[276]  E. Orenberg,et al.  Drugs in exacerbation of psoriasis. , 1986, Journal of the American Academy of Dermatology.

[277]  A. Safary,et al.  Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma. , 1986, European journal of cancer & clinical oncology.

[278]  C Fletcher,et al.  Consultation skills of young doctors: I--Benefits of feedback training in interviewing as students persist. , 1986, British medical journal.

[279]  J. Koppe,et al.  RESULTS OF 20-YEAR FOLLOW-UP OF CONGENITAL TOXOPLASMOSIS , 1986, The Lancet.

[280]  B. Plikaytis,et al.  Pneumococcal vaccine efficacy in selected populations in the United States. , 1986, Annals of internal medicine.

[281]  S. Reiss,et al.  Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. , 1986, Behaviour research and therapy.

[282]  T. Poynard,et al.  Psoriasis, alcohol, and liver disease. , 1985, British medical journal.

[283]  P Karma,et al.  Prevention of otitis media in children by pneumococcal vaccination. , 1985, American journal of otolaryngology.

[284]  George A. Zarb,et al.  Tissue-Integrated Prostheses: Osseointegration in Clinical Dentistry , 1985 .

[285]  J M Robins,et al.  Estimation of a common effect parameter from sparse follow-up data. , 1985, Biometrics.

[286]  C. Caspersen,et al.  Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. , 1985, Public health reports.

[287]  E. Shapiro,et al.  A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. , 1984, Annals of internal medicine.

[288]  R. Douglas,et al.  Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children. , 1984, The Journal of infectious diseases.

[289]  L. Kovács,et al.  Termination of very early pregnancy by RU 486--an antiprogestational compound. , 1984, Contraception.

[290]  M. Seligman,et al.  Attributional style and depressive symptoms among children. , 1984, Journal of abnormal psychology.

[291]  S. Y. Yip.  The prevalence of psoriasis in the Mongoloid race. , 1984, Journal of the American Academy of Dermatology.

[292]  L. Parish.  Clinics in dermatology , 1983 .

[293]  E. Rosenberg,et al.  Improvement of psoriasis of the scalp with ketoconazole. , 1982, Archives of dermatology.

[294]  S. Khan,et al.  The treatment of chronic psoriasis a two-centre comparative study. , 1981, The Practitioner.

[295]  D. Bentley,et al.  Pneumococcal vaccine in the institutionalized elderly: design of a nonrandomized trial and preliminary results. , 1981, Reviews of infectious diseases.

[296]  R. Austrian.  Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. , 1981, Reviews of infectious diseases.

[297]  C. Broome,et al.  Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. , 1980, New England Journal of Medicine.

[298]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.

[299]  S. Pollack,et al.  The Influence of Functional Use of Endosseous Dental Implants on the Tissue-implant Interface. I. Histological Aspects , 1979 .

[300]  J B Brunski,et al.  The Influence of Functional Use of Endosseous Dental Implants on the Tissue-implant Interface. II. Clinical Aspects , 1979, Journal of dental research.

[301]  M. Hilleman,et al.  Protective efficacy of pneumococcal polysaccharide vaccines. , 1977, JAMA.

[302]  A. Ammann,et al.  Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. , 1977, The New England journal of medicine.

[303]  R. Austrian.  Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines. , 1977, The Journal of infectious diseases.

[304]  R. Douglas,et al.  IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE Reduction of Adult Respiratory Mortality in a New Guinea Highlands Community , 1977, The Lancet.

[305]  P. Branemark,et al.  Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. , 1977, Scandinavian journal of plastic and reconstructive surgery. Supplementum.

[306]  R. D. Reid,et al.  Prevention of pneumococcal pneumonia by vaccination. , 1976, Transactions of the Association of American Physicians.

[307]  R. Austrian,et al.  Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus. , 1975, The Journal of infectious diseases.

[308]  S. Shuster.  Psoriatic alopecia. , 1972, The British journal of dermatology.

[309]  R. Emmrich,et al.  PNEUMONIA IN OLD AGE , 1947, Zeitschrift fur Alternsforschung.

[310]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[311]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[312]  J. Lavat.  [Ocular toxoplasmosis]. , 1952, Bulletin medical.

[313]  C. Macleod,et al.  Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. , 1945, The Journal of experimental medicine.

[314]  Surender Kumar,et al.  A Randomised Comparison of Oral and Vaginal Misoprostol for Medical Management of First Trimester Missed Abortion , 2022 .